Corrigendum to "Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018" [Drug Resist. Updates 37 (March) (2018) 17-39].

Sorbo, Maria C; Cento, Valeria; Di Maio, Velia C; Howe, Anita Y M; Garcia, Federico; Perno, Carlo F; Ceccherini-Silberstein, Francesca

Sorbo, Maria C; Cento, Valeria; Di Maio, Velia C; Howe, Anita Y M; Garcia, Federico; Perno, Carlo F; Ceccherini-Silberstein, Francesca.

Afiliación

Sorbo MC; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Cento V; Residency Program in Microbiology and Virology, Università degli Studi di Milano, Milan, Italy. Electronic address: valeria.cento@unimi.it.
Di Maio VC; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Howe AYM; Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, BC, Canada.
Garcia F; Clinical Microbiology Service, Hospital Universitario San Cecilio, Granada, Spain.
Perno CF; Department of Oncology and Oncohematology, Università degli Studi di Milano, Milan, Italy.
Ceccherini-Silberstein F; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.

Drug Resist Updat ; 40: 40-41, 2018 09.

Article en En | MEDLINE | ID: mdl-29680499

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google